Skip to main content
Signal8

McKechnie Duncan

SEC insider (Form 3/4/5 filer). CIK 0002062139. EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX). 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 2, 2026. Located in BOSTON, MA.

Companies McKechnie Duncan has filed insider reports for

  • VERTEX PHARMACEUTICALS INC / MA (VRTX): Officer, EVP, Chief Commercial Officer
McKechnie Duncan profile photo

McKechnie Duncan

CIK: 0002062139

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (41.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VERTEX PHARMACEUTICALS INC / MA logo
VRTX

VERTEX PHARMACEUTICALS INC / MA

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Jul 2, 2026
    Sale
    Direct
    1.5K shares at avg. $519.00$800K
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Mar 11, 2026
    Sale
    Direct
    2.6K shares at avg. $498.42$1.3M
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Mar 4, 2026
    Sale
    Direct
    2.4K shares at avg. $475.30$1.2M
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Feb 25, 2026
    Sale
    Direct
    2.4K shares at avg. $489.00$1.2M
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Feb 25, 2026
    Sale
    Direct
    2.5K shares at avg. $486.35$1.2M
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Feb 24, 2026
    Tax Payment
    Direct
    873 shares at avg. $485.11$424K
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Feb 17, 2026
    Award
    Direct
    5K shares-
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Feb 17, 2026
    Tax Payment
    Direct
    1.1K shares at avg. $483.75$555K
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Feb 13, 2026
    Tax Payment
    Direct
    2.3K shares at avg. $487.76$1.1M
  • VERTEX PHARMACEUTICALS INC / MA logo
    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Feb 10, 2026
    Tax Payment
    Direct
    1.1K shares at avg. $468.41$528K

1-10 of 12